Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intracoronary Stenting and Antithrombotic Regimen: Testing of a Six-week Versus a Six-month Clopidogrel Treatment Regimen in Patients With Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting
Brief Summary: The investigators hypothesize that reducing the duration of clopidogrel therapy from 6 months to 6 weeks after DES implantation is associated with improved clinical outcomes in patients on ASA and an oral anticoagulant.


Options:
A: Arm Label: Short triple; Type: EXPERIMENTAL; Interventions: Drug: aspirin, Drug: clopidogrel, Drug: oral anticoagulation | Arm Label: Long triple; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin, Drug: clopidogrel, Drug: oral anticoagulation | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): Long triple, Short triple | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): Long triple, Short triple | Intervention Type: DRUG; Name: oral anticoagulation; Assigned to Arm(s): Long triple, Short triple
B: Arm Label: 1. YM150 Dose V, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 2. YM150 Dose W, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 3. YM150 Dose X, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 4. YM150 Dose Y, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 5. YM150 Dose Y, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 6. YM150 Dose Z, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 7. Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YM150; Assigned to Arm(s): 1. YM150 Dose V, twice daily, 2. YM150 Dose W, once daily, 3. YM150 Dose X, twice daily, 4. YM150 Dose Y, once daily, 5. YM150 Dose Y, twice daily, 6. YM150 Dose Z, once daily | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 7. Placebo
C: Arm Label: Clopidogrel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel | Arm Label: Ticagrelor; Type: EXPERIMENTAL; Interventions: Drug: Ticagrelor | Intervention Type: DRUG; Name: Ticagrelor; Assigned to Arm(s): Ticagrelor | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Clopidogrel
D: Arm Label: Apixaban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Apixaban | Arm Label: Vitamin K Antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: vitamin K antagonist | Arm Label: Acetylsalicylic acid film coated tablet; Type: PLACEBO_COMPARATOR; Interventions: Drug: Acetylsalicylic acid | Arm Label: Placebo matching Acetylsalicylic acid film coated tablet; Type: PLACEBO_COMPARATOR; Interventions: Other: Acetylsalicylic acid placebo | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): Apixaban | Intervention Type: DRUG; Name: vitamin K antagonist; Assigned to Arm(s): Vitamin K Antagonist | Intervention Type: DRUG; Name: Acetylsalicylic acid; Assigned to Arm(s): Acetylsalicylic acid film coated tablet | Intervention Type: OTHER; Name: Acetylsalicylic acid placebo; Assigned to Arm(s): Placebo matching Acetylsalicylic acid film coated tablet

Answer: A